SHAREHOLDER ALERT: Law firm Pomerantz is investigating claims on behalf of NRx investors… | New
NEW YORK, Aug. 16, 2022 (GLOBE NEWSWIRE) — Pomerantz LLP is investigating claims on behalf of investors in NRx Pharmaceuticals, Inc. (“NRx” or the “Company”) (NASDAQ: NRXP; NRXPW). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529 ext. 7980. The investigation focuses on whether NRx andRead More →